Organic synthesis is the backbone of numerous industries, from pharmaceuticals and agrochemicals to advanced materials. At its core, it relies on precise manipulation of molecules using specific building blocks. Among these, 7-Bromo-1H-quinazolin-4-one (CAS 194851-16-6) has emerged as a particularly valuable intermediate for chemists aiming to construct complex organic structures. NINGBO INNO PHARMCHEM CO.,LTD. is a dedicated provider of such essential materials, supporting innovation in chemical synthesis.

The power of 7-Bromo-1H-quinazolin-4-one in organic synthesis stems from its inherent chemical properties. As a brominated heterocyclic compound, it offers a reactive handle for a multitude of transformations. The bromine atom is an excellent leaving group, making it amenable to nucleophilic substitution and, more importantly, a wide array of palladium-catalyzed cross-coupling reactions. These reactions, including the ubiquitous Suzuki-Miyaura coupling, are indispensable for forming new carbon-carbon bonds, a fundamental goal in creating complex organic molecules. Mastering these reactions with reliable reagents like 7-bromo-1h-quinazolin-4-one CAS 194851-16-6 significantly streamlines synthetic routes.

The demand for high-quality organic chemistry intermediates is ever-present. NINGBO INNO PHARMCHEM CO.,LTD. understands that the success of a synthetic endeavor often hinges on the purity and consistency of the starting materials. Therefore, the company ensures that its 7-Bromo-1H-quinazolin-4-one is supplied with a minimum purity of 97%. This high standard is crucial for achieving high yields and desired stereochemistry in multi-step syntheses. For chemists working on intricate projects, the availability of such reliable intermediates is a significant advantage.

Furthermore, the quinazolinone framework itself is a significant motif in many biologically active compounds. This makes 7-Bromo-1H-quinazolin-4-one a sought-after intermediate for medicinal chemists looking to explore new therapeutic avenues. Its incorporation into larger molecules can lead to compounds with a broad spectrum of pharmacological activities, including anti-cancer, anti-inflammatory, and antiviral properties. The strategic use of brominated heterocycles in drug design is a well-established practice, and this particular compound offers a direct entry into such chemical spaces.

When you partner with NINGBO INNO PHARMCHEM CO.,LTD., you gain access to a supplier committed to excellence. Beyond providing high-purity pharmaceutical intermediates, the company offers expertise and a responsive approach to customer needs. Whether you require small quantities for research or larger batches for scale-up, NINGBO INNO PHARMCHEM CO.,LTD. is equipped to meet your demands. The accessibility of key reagents like 7-Bromo-1H-quinazolin-4-one is vital for the continuous advancement of chemical science and industry.

In summary, 7-Bromo-1H-quinazolin-4-one is a powerful tool for organic chemists. Its reactivity and structural significance make it a cornerstone for various synthetic applications, particularly in the pharmaceutical sector. By providing this essential intermediate, NINGBO INNO PHARMCHEM CO.,LTD. empowers chemists to push the boundaries of what's possible in molecular design and synthesis.